We undertook this study to specifically analyze the potential risk of overtreatment defined as an HbA1c < 7% or an HbA1c < 6.5% in patients aged 75 years or older treated with drugs associated with a higher risk of hypoglycemia (insulin, sulfonylureas, or glinides). This evidence concerns the gene INS and Hypoglycemia.